Skip to main content
Clinical Trials/NCT01856387
NCT01856387
Unknown
Not Applicable

the Predictive Value of neutrophil-to Lymphocyte Ratio on Preeclampsia- Eclampsia

Zekai Tahir Burak Women's Health Research and Education Hospital1 site in 1 country600 target enrollmentMay 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Preeclampsia
Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Enrollment
600
Locations
1
Primary Endpoint
the effect of neutrophil lymphocyte ratio in preeclampsia eclampsia
Last Updated
12 years ago

Overview

Brief Summary

Neutrophil/lymphocyte ratio (NLR) is a marker of systemic inflammation and endothelial dysfunction. In recent years, it has been reported that the individual components of the differential white cell count, specifically the neutrophil and lymphocyte counts,may have clinical utility in predicting diseases. An elevated NLR has been shown to be a prognostic indicator in various malignancies. İn the literature, many studies have been shown that NLR have predictive value in determining the prognosis of various diseases (cardiac or noncardiac diseases ). However, little is known about the predictive values of NLR in pregnancy complications. This study aimed to evaluate the potential predictive value of NLR in preeclampsia- eclampsia.

Detailed Description

In recent years, have been reported that the individual components of the differential white cell count, specifically the neutrophil and lymphocyte counts, may have clinical utility in predicting diseases. An elevated NLR has been shown to be a prognostic indicator in various malignancies. İn the literatüre have been shown that NLR have predictive value in determining the prognosis of various diseases (cardiac or noncardiac diseases.However, little is known about the predictive values of NLR and PLR in gestational DM, preeclampsia and the other pregnancy complications. Retrospective data were collected for patients who was diagnosed with , preeclampsia- eclampsia, The NLR was defined as the absolute neutrophil count divided by the absolute lymphocyte count.

Registry
clinicaltrials.gov
Start Date
May 2013
End Date
May 2014
Last Updated
12 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Zekai Tahir Burak Women's Health Research and Education Hospital
Responsible Party
Principal Investigator
Principal Investigator

Ayse Kirbas

Ayse Kirbas, MD

Zekai Tahir Burak Women's Health Research and Education Hospital

Eligibility Criteria

Inclusion Criteria

  • pregnant women who developing preeclampsia eclampsia at pregnancy

Exclusion Criteria

  • Known chronically maternal disease multiple pregnancy older than 40 years old

Outcomes

Primary Outcomes

the effect of neutrophil lymphocyte ratio in preeclampsia eclampsia

Time Frame: up to 6 months

during 6 months ,the patients who was recorded with preeclampsi/eclampsia at our hospital ,first trimester whole blood count was taken and neutrophil lymphocyte ratio was calculated and recorded

Study Sites (1)

Loading locations...

Similar Trials